A summary analysis of 77 cases of chordoma treated with heavy ion (carbon ion) therapy at the Wuwei Heavy Ion Medical Center, demonstrating its high efficacy and low toxicity, suitable for patients with complex and large chordomas, especially those who are difficult to resect surgically or have recurrent after surgery.

Since the first heavy ion device in China was established in Wuwei, Gansu in 2012, we have developed an inseparable connection with particle therapy for cancer. From that time on, we embarked on the journey of constructing China's first heavy ion device.

A real-world data study of 170 cases of liver cancer treated with heavy ion therapy in Wuwei reveals survival breakthroughs, with a median survival period of 37 months and a 5-year survival rate of 41.01%, demonstrating the outstanding value of China's advanced technology in the treatment of liver cancer.

Brain tumors are the focus and difficulty in the field of radiation therapy, mainly including two types: primary brain gliomas and secondary brain metastases. The Wuwei Heavy Ion Center, relying on China's first heavy (carbon) ion therapy system, has accumulated rich clinical experience in the treatment of brain tumors. Since the first patient received heavy (carbon) ion therapy in November 2018, as of March 2026, the center has treated a total of 198 patients with brain tumors, including 76 patients with brain gliomas and 122 patients with brain metastases, totaling 198 cases of brain tumors.

Analysis of the therapeutic effect of (carbon) ion therapy for 164 sarcoma patients at the Wuwei Ion Medical Center, with a local control rate approaching 100% and significant survival rates, suitable for complex locations and refractory sarcomas, demonstrating high safety and efficacy.

The Gansu Wuer Heavy Ion Cancer Center has completed 345 cases of pancreatic cancer treatment, with a median survival period of 17 months, demonstrating the significant advantages of domestic heavy ion technology in the treatment of advanced pancreatic cancer, becoming the largest in the country.

Clinical analysis of carbon ion therapy for 78 esophageal cancer patients at the Wuwei Heavy Ion Medical Center showed significant treatment effects and improved survival rates, especially showing obvious advantages for advanced patients.

Analysis of the Effect of Photon Therapy in 348 Patients with Esophageal Cancer at the Wuwei Tumor Hospital in Gansu Province, Evaluating the Median Survival Period of 23 Months, 5-Year Survival Rate of 22.9%, which is Better than Traditional Radiotherapy Schemes, Providing Data Support for Modern Precise Radiotherapy.